Torres Sofía, Garcia-Palmero Irene, Bartolomé Rubén A, Fernandez-Aceñero María Jesús, Molina Elena, Calviño Eva, Segura Miguel F, Casal J Ignacio
Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain.
Surgical Pathology Department, Hospital Clínico, Madrid, Spain.
J Pathol. 2017 May;242(1):39-51. doi: 10.1002/path.4874. Epub 2017 Mar 7.
The process of liver colonization in colorectal cancer remains poorly characterized. Here, we addressed the role of microRNA (miRNA) dysregulation in metastasis. We first compared miRNA expression profiles between colorectal cancer cell lines with different metastatic properties and then identified target proteins of the dysregulated miRNAs to establish their functions and prognostic value. We found that 38 miRNAs were differentially expressed between highly metastatic (KM12SM/SW620) and poorly metastatic (KM12C/SW480) cancer cell lines. After initial validation, we determined that three miRNAs (miR-424-3p, -503, and -1292) were overexpressed in metastatic colorectal cancer cell lines and human samples. Stable transduction of non-metastatic cells with each of the three miRNAs promoted metastatic properties in culture and increased liver colonization in vivo. Moreover, miR-424-3p and miR-1292 were associated with poor prognosis in human patients. A quantitative proteomic analysis of colorectal cancer cells transfected with miR-424-3p, miR-503, or miR-1292 identified alterations in 149, 129, or 121 proteins, respectively, with an extensive overlap of the target proteins of the three miRNAs. Importantly, down-regulation of two of these shared target proteins, CKB and UBA2, increased cell adhesion and proliferation in colorectal cancer cells. The capacity of distinct miRNAs to regulate the same mRNAs boosts the capacity of miRNAs to regulate cancer metastasis and underscores the necessity of targeting multiple miRNAs for effective cancer therapy. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
结直肠癌肝转移的过程仍未得到充分描述。在此,我们探讨了微小RNA(miRNA)失调在转移中的作用。我们首先比较了具有不同转移特性的结直肠癌细胞系之间的miRNA表达谱,然后鉴定失调miRNA的靶蛋白以确定其功能和预后价值。我们发现,在高转移性(KM12SM/SW620)和低转移性(KM12C/SW480)癌细胞系之间有38种miRNA差异表达。经过初步验证,我们确定三种miRNA(miR-424-3p、-503和-1292)在转移性结直肠癌细胞系和人类样本中过表达。用这三种miRNA中的每一种对非转移性细胞进行稳定转导,可促进培养中的转移特性,并增加体内肝转移。此外,miR-424-3p和miR-1292与人类患者的不良预后相关。对用miR-424-3p、miR-503或miR-1292转染的结直肠癌细胞进行定量蛋白质组分析,分别鉴定出149、129或121种蛋白质的改变,这三种miRNA的靶蛋白有广泛重叠。重要的是,下调其中两种共同的靶蛋白CKB和UBA2,可增加结直肠癌细胞的细胞黏附和增殖。不同的miRNA调节相同mRNA的能力增强了miRNA调节癌症转移的能力,并强调了针对多种miRNA进行有效癌症治疗的必要性。版权所有© 2017英国和爱尔兰病理学会。由John Wiley & Sons, Ltd.出版。